(ALLO) Allogene Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Allogene Therapeutics | (ALLO) share price targets
Complete technical analysis of Allogene Therapeutics (ALLO) by charts plus indicators, forecast predictions and share price targets for Allogene Therapeutics (ALLO)
Allogene Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-30 View latest technical analysis
10 day averaged volume of Allogene Therapeutics is 1975230
Date | Daily Closing Price | Open | High | Low | Volume |
30 Wed Oct 2024 | 2.64 | 2.74 | 3.01 | 2.64 | 1.041 times |
29 Tue Oct 2024 | 2.80 | 2.68 | 3.01 | 2.67 | 1.663 times |
28 Mon Oct 2024 | 2.68 | 2.48 | 2.75 | 2.45 | 1.565 times |
25 Fri Oct 2024 | 2.44 | 2.56 | 2.58 | 2.44 | 1.058 times |
24 Thu Oct 2024 | 2.54 | 2.77 | 2.78 | 2.54 | 1.039 times |
23 Wed Oct 2024 | 2.77 | 2.80 | 2.85 | 2.70 | 1.673 times |
22 Tue Oct 2024 | 2.80 | 2.76 | 2.83 | 2.68 | 0.566 times |
21 Mon Oct 2024 | 2.80 | 2.82 | 2.90 | 2.78 | 0.794 times |
18 Fri Oct 2024 | 2.84 | 2.72 | 2.86 | 2.71 | 0.555 times |
17 Thu Oct 2024 | 2.69 | 2.82 | 2.85 | 2.68 | 0.427 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 2.6 as stoploss in an intra day buy trade for a target of 2.69. However, stock will show a bearish move below 2.6.
Share price targets for Allogene Therapeutics (ALLO)
Target Type | Value |
Downside Target | 2.01 |
Downside Target | 2.18 |
Downside Target | 2.37 |
Downside Target | 2.54 |
Upside Target | 2.68 |
Upside Target | 2.78 |
Upside Target | 2.87 |
Upside Target | 2.97 |
Upside Target | 3.01 |
Upside Target | 3.07 |
Upside Target | 3.67 |
Intraday share price targets for Allogene Therapeutics (ALLO)
Target Type | Value |
Downside Intraday Target | 2.39 |
Downside Intraday Target | 2.14 |
Upside Intraday Target | 2.95 |
Upside Intraday Target | 3.26 |
Upside Intraday Target | 2.7 |
Weekly technical analysis of Allogene Therapeutics (ALLO)
Date | Weekly Closing Price | Open | High | Low | Volume |
30 Wed Oct 2024 | 2.64 | 2.48 | 3.01 | 2.45 | 0.832 times |
25 Fri Oct 2024 | 2.44 | 2.82 | 2.90 | 2.44 | 1.605 times |
18 Fri Oct 2024 | 2.84 | 2.63 | 2.87 | 2.55 | 0.966 times |
11 Fri Oct 2024 | 2.65 | 2.72 | 2.78 | 2.54 | 0.611 times |
04 Fri Oct 2024 | 2.70 | 2.85 | 3.01 | 2.41 | 1.523 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Allogene Therapeutics (ALLO)
Date | Monthly Closing Price | Open | High | Low | Volume |
30 Wed Oct 2024 | 2.64 | 2.76 | 3.01 | 2.41 | 1.017 times |
30 Mon Sep 2024 | 2.80 | 2.58 | 3.07 | 2.37 | 1.038 times |
30 Fri Aug 2024 | 2.63 | 2.95 | 2.97 | 2.22 | 0.648 times |
31 Wed Jul 2024 | 2.94 | 2.33 | 3.67 | 2.01 | 0.887 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Allogene Therapeutics (ALLO)
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Allogene Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Allogene Therapeutics in short term and the sell signal is strong.
Allogene Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Allogene Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Allogene Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.7 and Allogene Therapeutics (ALLO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Allogene Therapeutics (ALLO) stock. Volume based technical analysis of Allogene Therapeutics (ALLO) stock is negative.
Allogene Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Allogene Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Allogene Therapeutics in short term and the sell signal is strong.
Allogene Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Allogene Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Allogene Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.7 and Allogene Therapeutics (ALLO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Allogene Therapeutics (ALLO) stock. Volume based technical analysis of Allogene Therapeutics (ALLO) stock is negative.
Allogene Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.